AIG
AVDL

American International Group’s Avadel Pharmaceuticals AVDL Stock Holding History

American International Group’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-796
Closed -$13K – 5010
2015
Q3 		$13K Buy
+796
New +$17.5K ﹤0.01% 4412

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

American International Group's AVDL Position: Q4 2015 in Review

American International Group sold out of Avadel Pharmaceuticals (AVDL) in Q4 2015, closing a stake of 796 shares — an estimated $13K sold.

American International Group first reported a position in AVDL in Q3 2015 and held it in 1 quarter. The position peaked at $13K in Q3 2015. 89 funds tracked by Wall St. Rank hold AVDL as of Q4 2015.

  • American International Group reported no remaining Avadel Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • American International Group sold 796 Avadel Pharmaceuticals shares in Q4 2015, an estimated $13K.
  • American International Group first reported a position in Avadel Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • American International Group's Avadel Pharmaceuticals position peaked at $13K in Q3 2015.
  • 89 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2015.

Based on American International Group's 13F filing for Q4 2015, filed 11 Feb 2016.